These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27322409)

  • 1. Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.
    Sapsirisavat V; Vongsutilers V; Thammajaruk N; Pussadee K; Riyaten P; Kerr S; Avihingsanon A; Phanuphak P; Ruxrungtham K;
    PLoS One; 2016; 11(6):e0157039. PubMed ID: 27322409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.
    Waning B; Diedrichsen E; Moon S
    J Int AIDS Soc; 2010 Sep; 13():35. PubMed ID: 20840741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
    Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
    PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.
    Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M
    JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies.
    Wang T; Hoag SW; Eng ML; Polli J; Pandit NS
    J Clin Pharm Ther; 2015 Feb; 40(1):68-75. PubMed ID: 25381836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic and branded drugs for the treatment of people living with HIV/AIDS.
    Bartlett JA; Muro EP
    J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients.
    Ramautarsing RA; van der Lugt J; Gorowara M; Sophonphan J; Ananworanich J; Lange JM; Burger DM; Phanuphak P; Ruxthungtham K; Avihingsanon A
    Antivir Ther; 2013; 18(2):249-52. PubMed ID: 22908131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic antiretroviral drugs in developing countries: friends or foes?
    Zucman D; Camara S; Gravisse J; Dimi S; Vasse M; Goudjo A; Choquet M; Peytavin G
    AIDS; 2014 Feb; 28(4):607-9. PubMed ID: 24378755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
    Waning B; Diedrichsen E; Jambert E; Bärnighausen T; Li Y; Pouw M; Moon S
    BMC Pediatr; 2010 Oct; 10():74. PubMed ID: 20950492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
    Chien CV
    PLoS One; 2007 Mar; 2(3):e278. PubMed ID: 17372625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community.
    Liu Y; Galárraga O
    Health Policy Plan; 2017 Mar; 32(2):170-177. PubMed ID: 28207060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025.
    Gupta A; Juneja S; Vitoria M; Habiyambere V; Nguimfack BD; Doherty M; Low-Beer D
    PLoS One; 2016; 11(10):e0164619. PubMed ID: 27736953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction.
    Rwagitinywa J; Sommet A; Palmaro A; Montastruc JL; Lapeyre-Mestre M
    Health Policy; 2018 Mar; 122(3):237-242. PubMed ID: 29398158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lack of bioavailability of generic lopinavir/ritonavir not prequalified by WHO marketed in Africa (Congo Brazzaville)].
    Camara S; Zucman D; Vasse M; Goudjo A; Guillard E; Peytavin G
    Bull Soc Pathol Exot; 2015 Feb; 108(1):46-8. PubMed ID: 25256250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.
    Dhamija P; Bansal D; Medhi B
    Curr HIV Res; 2009 Jul; 7(4):410-7. PubMed ID: 19601776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic substitution of antiretrovirals: patients' and health care providers' opinions.
    Kieran JA; O'Reilly E; O'Dea S; Bergin C; O'Leary A
    Int J STD AIDS; 2017 Oct; 28(12):1239-1246. PubMed ID: 28632475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of antiretroviral medicines: an uncertain problem.
    Do NT; Boupha P; Newton PN; Caillet C
    BMJ Glob Health; 2023 Mar; 8(3):. PubMed ID: 36921990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health.
    Beck EJ; Passarelli C; Lui I; Guichard AC; Simao M; De Lay P; Loures L
    Antivir Ther; 2014; 19 Suppl 3():117-23. PubMed ID: 25310477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Dionisio D; Gass R; McDermott P; Racalbuto V; Madeo M; Braghieri G; Crowley S; Pinheiro Edos S; Graaff P; Vasan A; Eksaengsri A; Moller H; Khanna AK; Kraisintu K; Juneja S; Nicolaou S; Sengupta A; Esperti F; Messeri D
    Curr HIV Res; 2007 Mar; 5(2):155-87. PubMed ID: 17346132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.